Baudax Bio Inc Ordinary Shares (OTC:BXRX) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Ratings for Baudax Bio Inc Ordinary Shares

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Baudax Bio Inc Ordinary Shares (BXRX) stock?

A

The latest price target for Baudax Bio Inc Ordinary Shares (OTC:BXRX) was reported by Noble Capital Markets on January 3, 2023. The analyst firm set a price target for $0.00 expecting BXRX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Baudax Bio Inc Ordinary Shares (BXRX)?

A

The latest analyst rating for Baudax Bio Inc Ordinary Shares (OTC:BXRX) was provided by Noble Capital Markets, and Baudax Bio Inc Ordinary Shares downgraded their market perform rating.

Q

When was the last upgrade for Baudax Bio Inc Ordinary Shares (BXRX)?

A

There is no last upgrade for Baudax Bio Inc Ordinary Shares

Q

When was the last downgrade for Baudax Bio Inc Ordinary Shares (BXRX)?

A

The last downgrade for Baudax Bio Inc Ordinary Shares happened on January 3, 2023 when Noble Capital Markets changed their price target from N/A to N/A for Baudax Bio Inc Ordinary Shares.

Q

When is the next analyst rating going to be posted or updated for Baudax Bio Inc Ordinary Shares (BXRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Baudax Bio Inc Ordinary Shares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Baudax Bio Inc Ordinary Shares was filed on January 3, 2023 so you should expect the next rating to be made available sometime around January 3, 2024.

Q

Is the Analyst Rating Baudax Bio Inc Ordinary Shares (BXRX) correct?

A

While ratings are subjective and will change, the latest Baudax Bio Inc Ordinary Shares (BXRX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Baudax Bio Inc Ordinary Shares (BXRX) is trading at is $0.02, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.